150 related articles for article (PubMed ID: 37393505)
1. Effects of the APOEɛ4 Allele on the Relationship Between Tau and Amyloid-β in Early- and Late-Onset Alzheimer's Disease.
Kang JM; Shin JH; Kim WR; Seo S; Seo H; Lee SY; Park KH; Na DL; Okamura N; Seong JK; Noh Y
J Alzheimers Dis; 2023; 94(3):1233-1246. PubMed ID: 37393505
[TBL] [Abstract][Full Text] [Related]
2. Association of Subcortical Structural Shapes With Tau, Amyloid, and Cortical Atrophy in Early-Onset and Late-Onset Alzheimer's Disease.
Lee EC; Kang JM; Seo S; Seo HE; Lee SY; Park KH; Na DL; Noh Y; Seong JK
Front Aging Neurosci; 2020; 12():563559. PubMed ID: 33192457
[TBL] [Abstract][Full Text] [Related]
3. Effects of ApoE genotype on clinical phenotypes in early-onset and late-onset Alzheimer's disease in China: Data from the PUMCH dementia cohort.
Dong L; Li J; Liu C; Mao C; Wang J; Lei D; Huang X; Chu S; Hou B; Feng F; Sha L; Xu Q; Gao J
Brain Behav; 2021 Nov; 11(11):e2373. PubMed ID: 34555265
[TBL] [Abstract][Full Text] [Related]
4. Associations Between Sub-Threshold Amyloid-β Deposition, Cortical Volume, and Cognitive Function Modulated by APOE ɛ4 Carrier Status in Cognitively Normal Older Adults.
Kang DW; Wang SM; Um YH; Kim NY; Lee CU; Lim HK
J Alzheimers Dis; 2022; 89(3):1003-1016. PubMed ID: 35964194
[TBL] [Abstract][Full Text] [Related]
5. Sex and APOE ε4 carrier effects on atrophy, amyloid PET, and tau PET burden in early-onset Alzheimer's disease.
Nemes S; Logan PE; Manchella MK; Mundada NS; La Joie R; Polsinelli AJ; Hammers DB; Koeppe RA; Foroud TM; Nudelman KN; Eloyan A; Iaccarino L; Dorsant-Ardón V; Taurone A; Thangarajah M; Dage JL; Aisen P; Grinberg LT; Jack CR; Kramer J; Kukull WA; Murray ME; Rumbaugh M; Soleimani-Meigooni DN; Toga A; Touroutoglou A; Vemuri P; Atri A; Day GS; Duara R; Graff-Radford NR; Honig LS; Jones DT; Masdeu J; Mendez MF; Musiek E; Onyike CU; Riddle M; Rogalski E; Salloway S; Sha SJ; Turner RS; Wingo TS; Womack KB; Wolk DA; Rabinovici GD; Carrillo MC; Dickerson BC; Apostolova LG;
Alzheimers Dement; 2023 Nov; 19 Suppl 9(Suppl 9):S49-S63. PubMed ID: 37496307
[TBL] [Abstract][Full Text] [Related]
6. Differential associations between neocortical tau pathology and blood flow with cognitive deficits in early-onset vs late-onset Alzheimer's disease.
Visser D; Verfaillie SCJ; Wolters EE; Coomans EM; Timmers T; Tuncel H; Boellaard R; Golla SSV; Windhorst AD; Scheltens P; van der Flier WM; van Berckel BNM; Ossenkoppele R
Eur J Nucl Med Mol Imaging; 2022 May; 49(6):1951-1963. PubMed ID: 34997294
[TBL] [Abstract][Full Text] [Related]
7. Association of Apolipoprotein E ɛ4 Allele With Clinical and Multimodal Biomarker Changes of Alzheimer Disease in Adults With Down Syndrome.
Bejanin A; Iulita MF; Vilaplana E; Carmona-Iragui M; Benejam B; Videla L; Barroeta I; Fernandez S; Altuna M; Pegueroles J; Montal V; Valldeneu S; Giménez S; González-Ortiz S; Muñoz L; Padilla C; Aranha MR; Estellés T; Illán-Gala I; Belbin O; Camacho V; Wilson LR; Annus T; Osorio RS; Videla S; Lehmann S; Holland AJ; Zetterberg H; Blennow K; Alcolea D; Clarimon J; Zaman SH; Blesa R; Lleó A; Fortea J
JAMA Neurol; 2021 Aug; 78(8):937-947. PubMed ID: 34228042
[TBL] [Abstract][Full Text] [Related]
8. Greater tau load and reduced cortical thickness in APOE ε4-negative Alzheimer's disease: a cohort study.
Mattsson N; Ossenkoppele R; Smith R; Strandberg O; Ohlsson T; Jögi J; Palmqvist S; Stomrud E; Hansson O
Alzheimers Res Ther; 2018 Aug; 10(1):77. PubMed ID: 30086796
[TBL] [Abstract][Full Text] [Related]
9. Effect of APOE ε4 genotype on amyloid-β and tau accumulation in Alzheimer's disease.
Baek MS; Cho H; Lee HS; Lee JH; Ryu YH; Lyoo CH
Alzheimers Res Ther; 2020 Oct; 12(1):140. PubMed ID: 33129364
[TBL] [Abstract][Full Text] [Related]
10. APOE ε4 carrier status and sex differentiate rates of cognitive decline in early- and late-onset Alzheimer's disease.
Polsinelli AJ; Logan PE; Lane KA; Manchella MK; Nemes S; Sanjay AB; Gao S; Apostolova LG
Alzheimers Dement; 2023 May; 19(5):1983-1993. PubMed ID: 36394443
[TBL] [Abstract][Full Text] [Related]
11. The Effect of Gender and APOE ɛ4 Status on Brain Amyloid-β Deposition in Different Age Groups of Mild Cognitively Impaired Individuals: A PET-CT Study.
Wang J; Wang M; Ren S; Huang L; He K; Li J; Hua F; Guan Y; Guo Q; Huang Q; Xie F
J Alzheimers Dis; 2023; 94(2):763-775. PubMed ID: 37334590
[TBL] [Abstract][Full Text] [Related]
12. Cortical hypometabolism reflects local atrophy and tau pathology in symptomatic Alzheimer's disease.
Strom A; Iaccarino L; Edwards L; Lesman-Segev OH; Soleimani-Meigooni DN; Pham J; Baker SL; Landau SM; Jagust WJ; Miller BL; Rosen HJ; Gorno-Tempini ML; Rabinovici GD; La Joie R;
Brain; 2022 Apr; 145(2):713-728. PubMed ID: 34373896
[TBL] [Abstract][Full Text] [Related]
13. Amyloid deposition in early onset versus late onset Alzheimer's disease.
Cho H; Seo SW; Kim JH; Suh MK; Lee JH; Choe YS; Lee KH; Kim JS; Kim GH; Noh Y; Ye BS; Kim HJ; Yoon CW; Chin J; Na DL
J Alzheimers Dis; 2013; 35(4):813-21. PubMed ID: 23507771
[TBL] [Abstract][Full Text] [Related]
14. The APOE4 effect: structural brain differences in Alzheimer's disease according to the age at symptom onset.
Forno G; Contador J; Pérez-Millan A; Guillen N; Falgàs N; Sarto J; Tort-Merino A; Castellví M; Bosch B; Fernández-Villullas G; Balasa M; Antonell A; Sala-Llonch R; Sanchez-Valle R; Hornberger M; Lladó A
Eur J Neurol; 2023 Mar; 30(3):597-605. PubMed ID: 36463489
[TBL] [Abstract][Full Text] [Related]
15. Segmented Linear Mixed Model Analysis Reveals Association of the APOEɛ4 Allele with Faster Rate of Alzheimer's Disease Dementia Progression.
Chen XR; Shao Y; Sadowski MJ;
J Alzheimers Dis; 2021; 82(3):921-937. PubMed ID: 34120907
[TBL] [Abstract][Full Text] [Related]
16. PICALM Variation Moderates the Relationships of APOE ɛ4 with Alzheimer's Disease Cerebrospinal Biomarkers and Memory Function Among Non-Demented Population.
Liu YB; Wang XJ; Tan L; Tan CC; Xu W;
J Alzheimers Dis; 2023; 96(4):1651-1661. PubMed ID: 38007652
[TBL] [Abstract][Full Text] [Related]
17. White matter hyperintensities are higher among early-onset Alzheimer's disease participants than their cognitively normal and early-onset nonAD peers: Longitudinal Early-onset Alzheimer's Disease Study (LEADS).
Eloyan A; Thangarajah M; An N; Borowski BJ; Reddy AL; Aisen P; Dage JL; Foroud T; Ghetti B; Griffin P; Hammers D; Iaccarino L; Jack CR; Kirby K; Kramer J; Koeppe R; Kukull WA; La Joie R; Mundada NS; Murray ME; Nudelman K; Rumbaugh M; Soleimani-Meigooni DN; Toga A; Touroutoglou A; Atri A; Day GS; Duara R; Graff-Radford NR; Honig LS; Jones DT; Masdeu J; Mendez MF; Musiek E; Onyike CU; Rogalski E; Salloway S; Sha S; Turner RS; Wingo TS; Wolk DA; Womack K; Beckett L; Gao S; Carrillo MC; Rabinovici G; Apostolova LG; Dickerson B; Vemuri P;
Alzheimers Dement; 2023 Nov; 19 Suppl 9(Suppl 9):S89-S97. PubMed ID: 37491599
[TBL] [Abstract][Full Text] [Related]
18. 18F-AV45 PET and MRI Reveal the Influencing Factors of Alzheimer's Disease Biomarkers in Subjective Cognitive Decline Population.
Zhao Z; Wang J; Wang Y; Liu X; He K; Guo Q; Xie F; Huang Q; Li Z
J Alzheimers Dis; 2023; 93(2):585-594. PubMed ID: 37066915
[TBL] [Abstract][Full Text] [Related]
19. Risk of Alzheimer's Disease in Obstructive Sleep Apnea Syndrome: Amyloid-β and Tau Imaging.
Elias A; Cummins T; Tyrrell R; Lamb F; Dore V; Williams R; Rosenfeld JV; Hopwood M; Villemagne VL; Rowe CC
J Alzheimers Dis; 2018; 66(2):733-741. PubMed ID: 30320587
[TBL] [Abstract][Full Text] [Related]
20. Topographical APOE ɛ4 Genotype Influence on Cerebral Metabolism in the Continuum of Alzheimer's Disease: Amyloid Burden Adjusted Analysis.
Seo EH; Kim SH; Park SH; Kang SH; Choo IH;
J Alzheimers Dis; 2016 Sep; 54(2):559-68. PubMed ID: 27567846
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]